The afterglow of the exhibition lingers on, while cooperation between pharmaceutical enterprises across the Taiwan Strait heats up again! Shanghai Bingtuo unlocks new possibilities with its "Golden Eye"

    Though BIO Asia-Taiwan held in late July concluded twenty days ago, the cooperation momentum between Shanghai Bintuo Intelligent Technology and Taiwan pharmaceutical enterprises remains exceptionally high.  

     During the exhibition, General Manager Xin Bin led a team to attend the event. They conducted in-depth exchanges with over 800 biomedical enterprises from more than 50 countries worldwide and paid visits to a number of leading pharmaceutical manufacturers in China's Taiwan region. The previously reached letters of intent for cooperation are now being implemented at an accelerated pace, and an intelligent upgrading drive for the pharmaceutical industry spanning across both sides of the Taiwan Strait is quietly underway.

Why has it gone viral? The "Golden Eye" boasts solid capabilities

     It is the independently developed "Golden Eye" intelligent visual inspection system from Shanghai Bingtuo that keeps pharmaceutical enterprises in Taiwan following up continuously.

    It boasts impressive test results: an inspection speed of 900,000 grains per hour and a consistent accuracy rate of 99%. It runs three times faster than conventional equipment with a 90% drop in missed inspections, enabling precise detection of microcracks as tiny as 0.02mm.

      这意味着，从药片到制剂，微小瑕疵都逃不过它的 “法眼”。也难怪展会后，仍有 10 余家台湾药企主动抛来橄榄枝。

Join hands across the Taiwan Strait to jointly explore new blue-ocean opportunities in the pharmaceutical industry.